INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious...
  • Yahoo Entertainment
  • Feb 23, 2021

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa - Yahoo Finance

Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflect… [+14745 chars]

More In health

Texas and Other States Reopen as Covid Cases Fall - msnNOW
  • New York Times
  • Mar 03, 2021

Texas said Tuesday that it was lifting its mask requirement and would allow businesses to fully reopen, the most expansive step by any state to remove coronavirus restrictions as Americans across the country are eager to emerge after a year of isolation in th…...